Literature DB >> 18573172

Pregnancy outcome in congenital dyserythropoietic anemia type I.

Hanna Shalev1, Galit Perez Avraham, Reli Hershkovitz, Amalia Levy, Eyal Sheiner, Itai Levi, Hannah Tamary.   

Abstract

OBJECTIVES: Congenital dyserythropoietic anemia type I (CDA I) is a rare inherited disease characterized by moderate to severe macrocytic anemia and abnormal erythroid precursors with nuclear chromatin bridges and spongy heterochromatin. Moderate to severe maternal anemia is a recognized independent risk factor for low birth weight (LBW) and complicated delivery. The aim of the study was to review the outcome of pregnancies in women with CDA I.
METHODS: The clinical and laboratory records of 28 spontaneous pregnancies in six Bedouin women with CDA I were reviewed. The results were compared with findings from a retrospective review of a large population-based registry including all pregnancies in Bedouin women during the same 15-yr period.
RESULTS: Eighteen pregnancies in women with CDA I (64%) were complicated. One pregnancy was aborted spontaneously in the first trimester and one resulted in a non-viable fetus (stillborn at 26 wk). Cesarean section (CS) was performed in 10 pregnancies (36%). Eleven of the 26 newborns (42%) had a LBW: six were born prematurely and five were small for gestational age. The odds ratio for CS in women with CDA I compared with healthy Bedouin women was 4.5 [95% confidence interval (CI) 1.2-10.3], and for a LBW infant, 5.5 (95% CI 2.4-12.3). Careful follow-up was associated with significantly better fetal outcome (P = 0.05).
CONCLUSIONS: Pregnancies in women with CDA I are at high risk for delivery-related and outcome complications. To improve fetal outcome, women with CDA I should be carefully monitored during pregnancy.

Entities:  

Mesh:

Year:  2008        PMID: 18573172     DOI: 10.1111/j.1600-0609.2008.01109.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

1.  Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha.

Authors:  Ayse Salihoglu; Tugrul Elverdi; Ahmet Emre Eskazan; Deniz Eyice; Isil Bavunoglu; Muhlis Cem Ar; Seniz Ongoren; Elif Guzel; Zafer Baslar; Aydin Tunckale; Nukhet Tuzuner; Teoman Soysal
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-21       Impact factor: 0.900

2.  Congenital dyserythropoiesis anemia type Ia with a novel CDAN1 mutation diagnosed by whole exome sequencing.

Authors:  Pei-Chin Lin; Chao-Neng Cheng; Hsi-Yuan Huang; Yu-Hsin Tseng; Ya-Sian Chang; Chien-Yu Lin; Jan-Gowth Chang
Journal:  Mol Genet Genomic Med       Date:  2020-03-11       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.